ReviewJournal of Cancer2026
A Comprehensive Review of Nanotechnological Innovations in Cancer: from Molecular Pathways to Clinical Applications.
Review in Journal of Cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Acidosis and the role of nanotechnology in mitigating cancer progression.Oncology reviews · 2026Review
- Nanomedicine strategies for remodeling the solid tumor microenvironment: stromal targeting, hypoxia modulation, and photodynamic immunotherapy.Frontiers in oncology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This review offers an inclusive overview of current cancer treatment options. It examines emerging trends in molecular mechanisms, therapeutic challenges, and nanotechnological innovations that may significantly improve patient outcomes. Cancer is a complex disease characterized by unregulated cellular proliferation, invasion of adjacent tissues, and metastasis. It remains a leading cause of death worldwide, with increasing incidence attributed to factors such as an aging demographic, lifestyle habits, and environmental stimuli. This review examines various cancer types, their associated risk factors, and critical molecular pathways, with the PI3K/Akt/mTOR and Wnt/β-catenin pathways, that facilitate cancer progression. The intricate process of metastasis, the leading cause of cancer fatalities, is examined in depth. The discussion encompasses a comprehensive analysis of diagnostic methods and conventional treatment modalities, including surgical intervention, radiation therapy, chemotherapy, and targeted therapies, and addresses their limitations, including toxicity, drug resistance, and unintended side effects. The advent of nanoparticle-based platforms in cancer therapy has facilitated significant progress in targeted drug delivery, enhanced imaging for prompt diagnosis, and the advancement of treatments, such as photothermal and photodynamic therapies. Nanoparticles may provide a vital function in overcoming drug resistance, thereby improving treatment effectiveness. Furthermore, this review emphasizes cancer prevention strategies, which include lifestyle changes and vaccination efforts. The oncological treatment landscape is poised for transformation through advancements in precision medicine, gene therapy, and artificial intelligence. Incorporating nanotechnology into these emerging strategies holds substantial potential for developing more personalized and effective cancer therapies with reduced adverse effects.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.